|View all cancer genomic applications||Understanding which genetic and epigenetic changes have biological and clinical significance is a big challenge. That's why Life Technologies is committed to providing highly accurate and affordable solutions, empowering cancer researchers to translate new discoveries into future clinical applications.|
- Life Technologies: Whole Genome Sequencing of Triple Negative Breast Cancer Reveals Previously Unreported Mutations
- Life Technologies: JAMA Study Demonstrates Efficacy of Life Technologies' Lung Cancer Test in Detecting Early Metastases, Supports Screening for Lung Cancer
- Life Technologies: Life Technologies introduces Ion AmpliSeq™ Community Panels
- Life Technologies: Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
Cancer Genomics Research Applications
With access to these innovative products and platforms, you can uncover the genetic variants and RNA signatures you need to power your next breakthrough.
|Laser Capture Microdissection |
Isolate pure populations of cancer cells from tumor tissues.
|Cancer Gene Expression Analysis
Uncover RNA signatures that provide new insights in the identification, characterization, and progression of cancer subtypes.
|Whole Genome and Exome Sequencing |
Discover new cancer biomarkers using whole genome and exome sequencing.
Identify epigenetic changes that occur during tumor progression.
|Targeted Sequencing for Cancer Mutation Detection
Rapidly screen hundreds of cancer genes with as little as 10 ng of FFPE DNA.
|Characterization of Cancer Biomarkers |
Uncover the biological significance of identified tumor biomarkers and RNA signatures using the Oncomine database.
|Cancer Genotyping Assays: Somatic and Germline |
Accurately screen or confirm somatic and germline variants of choice using sequencing and real-time PCR.
Cancer Genomics Webinars
Learn how Life Technologies solutions are being used to uncover genetic variants across the cancer genome and overcome many of the challenges inherent in working with tumor tissues in the research setting.
|Ion Torrent™ Amplicon Sequencing— A Tool to Advance Clinical Research||Rapid innovation and flexibility of the PGM™ and Ion Proton™ Sequencers drives the cancer genome research laboratory into the future|
|Speaker: Dr. Stephen Yip BC Cancer Agency, Vancouver General Hospital Duration: 15.03||Speaker: Dr. Joe Boland Director of Research and Development, Cancer Genomics Research Laboratory, National Cancer Institute (NCI) Duration: 28.11|
Featured Cancer Genomics Posters
Access scientific posters demonstrating new results and methodologies in cancer genomics from recent scientific conferences.
Come Meet Us
Come meet us in person and learn more about our new solutions for cancer genomics at one of these upcoming scientific conferences or local events.
|American Society of Clinical Oncology (ASCO) Annual Meeting||Chicago, United States||May 31–June 4|
|European Society of Human Genetics (ESHG) European Human Genetics Conference||Paris, France||June 8–11|
|The 39th Annual Meeting of the Korean Cancer Association||Seoul, South Korea||June 13–14|
|European Association for Cancer Research (EACR) Summer Conference||Cambridge, United Kingdom||June 25–28|